Table 5

Prevalence of IR and AR% in IRRF-Free and IRRF-Optimal groups among US adult, 2007–2014*

TG (mg/dL)IRRF-Free (N=2478)TG (mg/dL)IRRF-Optimal (N=1414)
IR (n)Prevalence of IR (%)AR%IR (n)Prevalence of IR (%)AR%
<79.5552.9<81.5342.5
79.5–20014511.27481.5–150551279
Total2006.9Total895.7
  • *Data are from the National Health and Nutrition Examination Surveys. All data except for sample size are weighted accounting for the complex study design according to the directions of the National Centre for Health Statistics.

  • AR%, attributable risk per cent; IR, insulin resistance; IRRF, insulin resistance risk factor; TG, triglyceride.